March 21 (Reuters) - Check Cap Ltd CHEK.O :
* CHECK-CAP ISSUES AN UPDATE TO SHAREHOLDERS
* CHECK CAP- FOLLOWING INTERNAL ASSESSMENT, DETERMINED
EFFICACY
RESULTS DO NOT MEET GOAL IN ORDER TO PROCEED TO POWERED PORTION
OF U.S. PIVOTAL STUDY
* CHECK CAP LTD - COMPANY PLANS TO CONTINUE CONDUCTING ITS
CALIBRATION STUDIES, ALBEIT AT A SLOWER PACE, TO COLLECT
ADDITIONAL CLINICAL DATA
* CHECK CAP LTD - COMPANY IS ALSO IMPLEMENTING A COST
REDUCTION
PLAN, IN ORDER TO EXTEND ITS CASH RUNWAY
* CHECK CAP LTD - INITIATION OF POWERED PORTION OF U.S.
PIVOTAL
STUDY THAT WAS EXPECTED IN MID-2023 IS THEREFORE TEMPORARILY
POSTPONED
* CHECK CAP LTD - CO TO CONDUCT ADDITIONAL CLINICAL DATA
ANALYSIS
AND APPROACH FDA TO MAKE AMENDMENTS TO U.S. PIVOTAL STUDY
PROTOCOL
Source text for Eikon: ID:nPn8Bh502a
Further company coverage: CHEK.O
((Reuters.Briefs@thomsonreuters.com;;))